Tomorrow Galapagos will publish its past quarter's results. For this year Galapagos 's revenue will be around 170,75 million euros. This is according to the average of the analysts' estimates. This is slightly more than 2016's revenue of 155,92 million euros.
The analysts expect for 2018 a net loss of 130 million euros. The majority of the analysts expects for this year a loss per share of 3,16 euros. The price/earnings-ratio therefore equals -24,89.
For this year analysts don't expect the company to pay a dividend.The average dividend yield of the biotech companies equals a moderate 1 percent.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.